Questions
- Why do you measure only the cross-sectional area of the dural sac for central stenosis?
- Do we have any restrictions to deploying in any country in the world?
- How did you conduct your Clinical trials in Europe?
- Can we integrate besides being through a platform?
- Do you plan to add scoliosis to the detected pathologies?
- When do you plan to add Мodic changes?
- Do you plan on adding Polish, Finnish, and Danish languages?
- Do we detect recess stenosis?
- Do we detect spondyloarthritis?
- Where did you conduct your peer-reviewed study?
- Where have you been integrated?
- Where do you have customers from?
- What deep-learning method is used for our segmentation and classification?
- How was the data shared with us during the clinical trials?
- What is the duration of the pilot phase that CoLumbo offers?
- Do we plan to support hypoplasia?
- Can the segmentation be changed or corrected in case the radiologists note some discrepancies?
- Is Transition Vertebra (transitional abnormality) supported by CoLumbo?
- What is your pricing model?
- Is your CE mark MDR or MDD?
- Can your software be installed on a local server?
- Can the software detect and give measurements for the different spine parts?
- Do you have an interface for the radiology system?
- Is the structured report that you provide your development, or another 3rd party has create it?
- How do you differentiate pathology from a normal state of the spine? Where do you cut the line between pathology and a normal state?
- How do you measure scoliosis?
- Which languages does the report support?
- Is there a priority in the findings of the software?
- How much time does it take for CoLumbo to perform an analysis on a study?
- Do you open the UI as an application or do you see only the report?
- Does CoLumbo integrate seamlessly with every PACS provider?
- What are the minimum system requirements?
- What is not supported by CoLumbo?
- Is CoLumbo vendor agnostic?
- What is the accuracy of the software?
- What are the Risks, Contraindications and Adverse Side Effects of CoLumbo
- We’d like to understand the delivery of CoLumbo.
- Does CoLumbo cover the whole spine?
- Do we support patients who have pathologies detected on each level?
- Can the radiologist just sign the report without checking it?
- What will future versions of CoLumbo include?
- Are you aiming for full automation of the segmentation?
- What acquisition sequences do you consider?
- Are CoLumbo reports exportable?
- Few measurements in the research version are shown on the display design of the version intended for release. Why?
- What is the sensitivity and the specificity of CoLumbo?
- What are the prices? Will some radiologists not be willing to buy a product unless for a one-time payment?
- Are you planning to obtain approval or clearance for the USA, Canada, Australia, and Japan?
- How do you see the high burden on the regulatory side, given the large number of features that CoLumbo has?
- Can Smart Soft Healthcare provide CoLumbo output to PACS or third party viewers?
- What do you do if some hospitals do not use the cloud due to national regulations or other reasons?
- Are there any constraints in product deployment?
- How does CoLumbo run, i.e., on what software does it run?
- Is fat suppression used?
- What deep-learning techniques are used?
- Can CoLumbo be used without having to change/modify the scanning protocols?
- Shall the user be able to define a custom threshold so that there are minimum false negatives?
- Does Columbo need the T1 series?
- Can you accurately detect levels if there are transitional vertebra?
- Will the user be able to correct the results and edit the report?
- Will the user be able to quickly navigate to the pathological level?
- Is a radiologist needed anymore?
- Does your software support post-operative patients?
- If an unsupported pathology is added to a current report, can it become permanent in the next studies?
- Does the system work with previously analyzed images?